Literature DB >> 1931005

The DiGeorge anomaly.

R Hong1.   

Abstract

The DiGeorge anomaly, DGA (formerly termed DiGeorge syndrome), is now known to be a developmental field defect in which pharyngeal pouch derivatives do not arise, usually because of inadequate neural crest contributions. The conditions in which this occurs include exposure to teratogens, cytogenetic abnormalities, and Mendelian disorders. As a result, the facies and cardiovascular defects which occur are very characteristic. Two rare conotruncal anomalies, type B interrupted aortic arch and truncus arteriosus account for over half of the cardiac lesions seen in DGA. Failure of descent of the thymus is extremely common in DGA, but immunodeficiency which requires correction occurs only in approximately 25% of the cases. The term, complete DGA, should be reserved for those patients in need of reconstitution of the immune system. One can identify those patients requiring treatment of the thymic defect by T cell enumeration and in vitro proliferation assays. Two alternatives for therapy are thymus transplantation and bone marrow transplantation from a HLA matched sibling.

Entities:  

Mesh:

Year:  1991        PMID: 1931005

Source DB:  PubMed          Journal:  Immunodefic Rev        ISSN: 0893-5300


  7 in total

1.  Thymic microenvironment reconstitution after postnatal human thymus transplantation.

Authors:  Bin Li; Jie Li; Blythe H Devlin; M Louise Markert
Journal:  Clin Immunol       Date:  2011-04-16       Impact factor: 3.969

2.  Mechanisms of tolerance to parental parathyroid tissue when combined with human allogeneic thymus transplantation.

Authors:  Ivan K Chinn; John A Olson; Michael A Skinner; Elizabeth A McCarthy; Stephanie E Gupton; Dong-Feng Chen; Francisco A Bonilla; Robert L Roberts; Maria G Kanariou; Blythe H Devlin; M Louise Markert
Journal:  J Allergy Clin Immunol       Date:  2010-09-15       Impact factor: 10.793

3.  T cell receptor repertoire and function in patients with DiGeorge syndrome and velocardiofacial syndrome.

Authors:  M Pierdominici; M Marziali; A Giovannetti; A Oliva; R Rosso; B Marino; M C Digilio; A Giannotti; G Novelli; B Dallapiccola; F Aiuti; F Pandolfi
Journal:  Clin Exp Immunol       Date:  2000-07       Impact factor: 4.330

4.  Normalization of the peripheral blood T cell receptor V beta repertoire after cultured postnatal human thymic transplantation in DiGeorge syndrome.

Authors:  C M Davis; T M McLaughlin; T J Watson; R H Buckley; S E Schiff; L P Hale; B F Haynes; M L Markert
Journal:  J Clin Immunol       Date:  1997-03       Impact factor: 8.317

5.  Long-term tolerance to allogeneic thymus transplants in complete DiGeorge anomaly.

Authors:  Ivan K Chinn; Blythe H Devlin; Yi-Ju Li; M Louise Markert
Journal:  Clin Immunol       Date:  2007-12-26       Impact factor: 3.969

6.  Review of 54 patients with complete DiGeorge anomaly enrolled in protocols for thymus transplantation: outcome of 44 consecutive transplants.

Authors:  M Louise Markert; Blythe H Devlin; Marilyn J Alexieff; Jie Li; Elizabeth A McCarthy; Stephanie E Gupton; Ivan K Chinn; Laura P Hale; Thomas B Kepler; Min He; Marcella Sarzotti; Michael A Skinner; Henry E Rice; Jeffrey C Hoehner
Journal:  Blood       Date:  2007-02-06       Impact factor: 22.113

7.  Characterization of cultured thymus tissue used for transplantation with emphasis on promiscuous expression of thyroid tissue-specific genes.

Authors:  Bin Li; Jie Li; Chia-San Hsieh; Laura P Hale; Yi-Ju Li; Blythe H Devlin; M Louise Markert
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.